Skip to main navigation Skip to search Skip to main content

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

  • A. S. Whittemore
  • , R. R. Balise
  • , P. D.P. Pharoah
  • , R. A. DiCioccio
  • , I. Oakley-Girvan
  • , S. J. Ramus
  • , M. Daly
  • , M. B. Usinowicz
  • , K. Garlinghouse-Jones
  • , B. A.J. Ponder
  • , S. Buys
  • , R. Senie
  • , I. Andrulis
  • , E. John
  • , J. L. Hopper
  • , M. S. Piver
  • Stanford University
  • University of Cambridge
  • Roswell Park Cancer Institute
  • Cancer Prevention Institute of California
  • University College London
  • University of Utah
  • Columbia University
  • Cancer Care Ontario
  • University of Melbourne

Research output: Contribution to journalArticlepeer-review

137 Scopus citations

Fingerprint

Dive into the research topics of 'Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science